Latest Patreon Talks, 6/10 through 6/12: Analysis of “New York Times” Print Edition for 6/10/2022

In the lat­est Patre­on talks, Mr. Emory goes through the West­ern print edi­tion of “The New York Times,” pre­sent­ing the deep polit­i­cal and his­tor­i­cal con­text under­ly­ing the arti­cles and op-ed pieces. On Sun­day, 6/12, Dave dis­cuss­es the psy­cho­log­i­cal and soci­o­log­i­cal aspects of the Covid-19 pan­dem­ic, includ­ing spec­u­la­tion con­cern­ing the “Bio-Psy-Op-Apoc­a­lypse’s effect on the pub­lic reac­tion to the Ukraine War. Ukrain­ian tele­vi­sion anchor quotes Adolf Eich­mann ver­ba­tim in this video from UKRAINE 24. This video of Ukraine’s top mil­i­tary med­ical offi­cer dis­cussing an order to cas­trate Russ­ian males is an eye-open­er. WFMU-FM is pod­cast­ing For The Record–You can sub­scribe to the pod­cast HERE. Mr. Emory emphat­i­cal­ly rec­om­mends that listeners/readers get the 32GB flash dri­ve con­tain­ing all of Mr. Emory’s 43 years on the air, plus a library of old anti-fas­cist books on easy-to-down­load PDF files.

Is There a Doctor in the Haus? (“Paging Dr. Mengele”) Part 2

In a pre­vi­ous post, we not­ed col­lab­o­ra­tion between Josef Mengele–the infa­mous “Angel of Death” of Auschwitz–and the U.S. gov­ern­ment, via Paraguayan dic­ta­tor Alfre­do Stroess­ner. Some of our dis­cus­sion con­cern­ing “The Oswald Insti­tute of Virol­o­gy” might seem to some lis­ten­ers to be “a long way from home,” so to speak. In FTR#1147, we not­ed that ele­ments of U.S. intel­li­gence appear to have pro­tect­ed Men­gele, as part of their clan­des­tine spon­sor­ship of the post­war Nazi dias­po­ra. We high­light this because Men­gele was not an iso­lat­ed exam­ple, but rather char­ac­ter­is­tic of a much larg­er and broad-based phe­nom­e­non. “. . . . By July 1945 Josef Men­gele had been cap­tured and iden­ti­fied at an allied pris­on­er-of-war camp. Forty years lat­er an eye­wit­ness told a con­gres­sion­al com­mit­tee how guards knew Men­gele’s name, and also the gen­er­al nature of his crimes as doc­tor, exper­i­menter, and exe­cu­tion­er at Auschwitz.’ Also in 1985, the Simon Wiesen­thal Cen­ter in Los Ange­les released doc­u­ments obtained from the U.S. Army under the Free­dom of Infor­ma­tion Act, accord­ing to which Men­gele “may have been arrest­ed by U.S. author­i­ties in Aus­tria in 1947 and sub­se­quent­ly released. ’ . . . .” In FTR#664, we not­ed tes­ti­mo­ny at the Nurem­berg tri­als to the effect that Men­gele filled out paper­work  before his infa­mous exper­i­ments on twins, a copy of which went to the Kaiser Wil­helm Insti­tute, which received a great deal of fund­ing from the Rock­e­feller Foun­da­tion. Men­gele’s post­ing at Auschwitz was due to a superior/colleague at the Kaiser Wil­helm Insti­tute, who sug­gest­ed that it would be a good career move, as high­light­ed in, among oth­er pro­grams, FTR#908. WFMU-FM is pod­cast­ing For The Record–You can sub­scribe to the pod­cast HERE. Mr. Emory emphat­i­cal­ly rec­om­mends that listeners/readers get the 32GB flash dri­ve con­tain­ing all of Mr. Emory’s 43 years on the air, plus a library of old anti-fas­cist books on easy-to-down­load PDF files.

FTR #1160 Bio-Psy-Op Apocalypse Now, Part 20: An Ounce of Prevention, Part 5

The pro­gram begins with dis­cus­sion of oper­a­tional links between the Nazi/GOP milieu ana­lyzed in FTR #1159 and ele­ments we have ana­lyzed in the con­text of the desta­bi­liza­tion of Chi­na. (For the con­ve­nience of the lis­ten­er and read­er, key points of that dis­cus­sion are includ­ed in the broad­cast and below in this descrip­tion.)

In FTR #‘s 1103, 1143, 1144, 1153 and 1154, we detailed the pres­ence of OUN/B‑connected ele­ments in Hong Kong and work­ing in a pro­pa­gan­da role vis a vis the Uighurs in Xin­jiang province. In Hong Kong, ele­ments of the Azov Bat­tal­ion and Pravy Sek­tor (Right Sec­tor) have been active in con­junc­tion with the “pro-democ­ra­cy” move­ment in Hong Kong (under the aus­pices of an EU NGO.)

Ger­man nation­al and End Times Chris­t­ian Adri­an Zenz, a fel­low with the Vic­tims of Com­mu­nism Memo­r­i­al Foun­da­tion, has been the go-to fig­ure for West­ern media on the alleged per­se­cu­tion of the Uighurs in Xin­jiang Province. The Vic­tims of Com­mu­nism Memo­r­i­al Foun­da­tion is a sub­sidiary ele­ment of the Cap­tive Nations Com­mit­tee and the OUN/B.

In pre­vi­ous pro­grams, we exam­ined in detail the activ­i­ty of Peter Daszak and his Eco­Health Alliance–an orga­ni­za­tion craft­ed to “pre­vent” future pan­demics, yet net­worked with the Pen­ta­gon and oth­er nation­al secu­ri­ty bod­ies in work dis­turbing­ly sug­ges­tive of bio­log­i­cal war­fare research.

Join­ing Daszak in a com­mis­sion assem­bled by the pres­ti­gious British med­ical jour­nal The Lancet is Jef­frey Sachs, eco­nom­ic advis­er to Bernie Sanders and AOC and the prin­ci­pal eco­nom­ic advis­er to Russ­ian pres­i­dent Boris Yeltsin. Sachs’ advice drove the Russ­ian econ­o­my back to the Stone Age.

In this pro­gram we detail the strong, eugeni­cist over­lap between “main­stream” anti-abor­tion orga­ni­za­tions and their close­ly linked white suprema­cist col­leagues. Seek­ing to max­i­mize the birth rate of “Aryan” off­spring and their per­cent­age in the world’s pop­u­la­tion, they may be seen as being part of a polit­i­cal con­tin­u­um which includes the Third Reich.

” . . . . Coex­ist­ing in abor­tion oppo­si­tion is . . . . a white suprema­cist ide­ol­o­gy that only desires to pre­vent white women from obtain­ing abor­tions, but uses uni­ver­sal oppo­si­tion to abor­tion as a prag­mat­ic screen for its goals. As Kath­leen Belew, author of Bring the War Home: The White Pow­er Move­ment in Para­mil­i­tary Amer­i­ca, told The Nation in an inter­view in Sep­tem­ber, for white suprema­cists, ‘oppos­ing abor­tion, oppos­ing gay rights, oppos­ing fem­i­nism, in white pow­er dis­course, all of this is tied to repro­duc­tion and the birth of white chil­dren.’ . . . Tim Bish­op, a rep­re­sen­ta­tive of the white nation­al­ist Aryan Nations, said, ‘Lots of our peo­ple join [the anti-abor­tion move­ment]…. It’s part of our Holy War for the pure Aryan race.’ . . . . ”

Cen­tral to our analy­sis is a spec­u­la­tive, yet ter­ri­fy­ing biotech­no­log­i­cal element–gene dri­ve tech­nol­o­gy. We have spo­ken about this in numer­ous pre­vi­ous pro­grams.

” . . . . Gene dri­ves have been dubbed an ‘extinc­tion tech­nol­o­gy’ and with good rea­son: gene dri­ve organ­isms are cre­at­ed by genet­i­cal­ly engi­neer­ing a liv­ing organ­ism with a par­tic­u­lar trait, and then mod­i­fy­ing the organism’s repro­duc­tive sys­tem in order to always force the mod­i­fied gene onto future gen­er­a­tions, spread­ing the trait through­out the entire pop­u­la­tion. . . .”

” . . . . the Bill and Melin­da Gates Foun­da­tion (BMGF) is forc­ing dan­ger­ous gene dri­ve tech­nolo­gies onto the world. BMGF is either the first or sec­ond largest fun­der of gene dri­ve research (along­side the shad­owy U.S. mil­i­tary organ­i­sa­tion Defense Advanced Research Projects Agency [DARPA] ). . . .”

Just imag­ine what such technology–applied to human repro­duc­tive capacity–could do when deployed by fas­cist and Nazi ele­ments in the military/medical estab­lish­ment!

The emer­gence of such a devel­op­ment is being facil­i­tat­ed:

” . . . . a pri­vate PR firm called Emerg­ing Ag, was paid US$1.6 mil­lion by the BMGF. Part of their work involved coor­di­nat­ing the ‘fight back against gene dri­ve mora­to­ri­um pro­po­nents,’ as well as run­ning a covert advo­ca­cy coali­tion to exert influ­ence on the Unit­ed Nations Con­ven­tion on Bio­log­i­cal Diver­si­ty (CBD), the key body for gene dri­ve gov­er­nance. After calls in 2016 for a glob­al mora­to­ri­um on the use of gene dri­ve tech­nol­o­gy, the CBD sought input from sci­en­tists and experts in an online forum. Emerg­ing Ag recruit­ed and coor­di­nat­ed over 65 experts, includ­ing a Gates Foun­da­tion senior offi­cial, a DARPA (Defense Advanced Research Project Agency) offi­cial, and gov­ern­ment and uni­ver­si­ty sci­en­tists, in an attempt to flood the offi­cial UN process with their coor­di­nat­ed inputs. . . .”

At the con­clu­sion of the pro­gram we present a very dis­turb­ing hypo­thet­i­cal con­cept: we fear that the effort to find viral pathogens around the world and make them more infec­tious via gain-of-func­tion manip­u­la­tions is intend­ed to real­ize a glob­al, eugeni­cist, exter­mi­na­tion­ist and white suprema­cist agen­da by cre­at­ing pan­demics in the Third World, prof­it enor­mous­ly by mak­ing vac­cines to treat those pan­demics and intro­duce gene dri­ve tech­nol­o­gy into those pop­u­la­tions via the vac­cines in order to dimin­ish repro­duc­tion in those pop­u­la­tions.

The mRNA and DNA vac­cines being pro­duced by the DARPA-sup­port­ed Mod­er­na and Inovio firms should be con­sid­ered in con­nec­tion with this night­mar­ish work­ing hypoth­e­sis. 

Supplement to FTR #‘s 1157, 1158 and 1159

This post sup­ple­ments and is intend­ed to call atten­tion to FTR #‘s 1157, 1158 and 1159. A con­sum­mate­ly impor­tant arti­cle about Peter Daszak (right) and the Eco­Health Alliance pro­vides trou­bling insights into the uneven pro­fes­sion­al track record of Daszak and the pro­found involve­ment of the orga­ni­za­tion he heads with the Pen­ta­gon and oth­er U.S. nation­al secu­ri­ty estab­lish­ment insti­tu­tions. Exem­pli­fy­ing Eco­Health Alliance’s work is a Pen­ta­gon con­tract with Tan­za­nia, research­ing CCHF–Crimean-Congo Hem­or­rhag­ic Fever. ” . . . . Eco­Health Alliance has a $5‑million Pen­ta­gon con­tract, ‘Crimean-Con­go Hem­or­rhag­ic Fever: Reduc­ing an Emerg­ing Health Threat in Tan­za­nia.’  Crimean-Con­go Hem­or­rhag­ic Fever (CCHF) is a tick-borne dis­ease, orig­i­nal­ly only infect­ing ani­mals. . . . There was only ever one case of CCHF in Tan­za­nia, and that was in 1986. . . . Gain-of-func­tion research on CCHF is being con­duct­ed at the U.S. Depart­ment of Agriculture’s Nation­al Bio and Agro-Defense Facil­i­ty (NBAF) . . . . (The Nation­al Bio and Agro Defense Facil­i­ty will take over the mis­sion of the Plum Island Ani­mal Dis­ease Cen­ter and become the lead facil­i­ty for For­eign Ani­mal Dis­ease research.) . . .”

FTR #‘s 1157, 1158 and 1159–Bio-Psy-Op Apocalypse Now, Parts 17, 18 and 19: An Ounce of Prevention, Parts 2, 3 and 4

A note­wor­thy devel­op­ment in the Covid-19 “op” con­cerns the selec­tion of experts to over­see The Lancet’s inves­ti­ga­tion of the ori­gins of the SARS CoV‑2.

In FTR #1156, we looked at the involve­ment of known U.S. intel­li­gence cut-outs–notably USAID–and their fund­ing of pro­grams osten­si­bly aimed at pre­vent­ing epi­demics. Those pro­grams involved the “Gain-of-Func­tion” muta­tion of bat-borne coro­n­avirus­es, cre­at­ing nov­el “chimeric” virus­es that nev­er exist­ed before.

The osten­si­ble pur­pose was to “pre­vent” future epi­demics. We won­dered in FTR #1156 if those osten­si­ble epi­dem­ic “pre­ven­tion” pro­grams may have masked epi­dem­ic prop­a­ga­tion pro­grams, rather like Unit 731.

Peter Daszak of the Eco­Health Alliance was select­ed to lead the project.

His per­spec­tive would, on the sur­face, appear to be less than objec­tive, in as much as he cham­pi­oned the very type of GOF exper­i­ments that are at the cen­ter of this inquiry.

Of inter­est, as well, is the selec­tion of Jef­frey Sachs, an econ­o­mist, mem­ber of the [Bernie] Sanders Insti­tute, eco­nom­ic advis­er to Bernie Sanders, eco­nom­ic advis­er to AOC and, most impor­tant­ly, head of the [part­ly] gov­ern­ment financed Har­vard Insti­tute of Inter­na­tion­al Devel­op­ment which (as advis­ers to Boris Yeltsin) drove the Russ­ian econ­o­my back to the Stone Age.

Sachs has no med­ical or sci­en­tif­ic cre­den­tials.

A con­sum­mate­ly impor­tant arti­cle about Daszak and the Eco­Health Alliance pro­vides trou­bling insights into the uneven pro­fes­sion­al track record of Daszak and the pro­found involve­ment of the orga­ni­za­tion he heads with the Pen­ta­gon and oth­er U.S. nation­al secu­ri­ty estab­lish­ment insti­tu­tions.

Eco­Health Alliance looks dis­turbing­ly like an orga­ni­za­tion that fronts for ele­ments and indi­vid­u­als involved with bio­log­i­cal war­fare research.

“Peter Daszak, Pres­i­dent of Eco­Health Alliance, is a top sci­en­tif­ic col­lab­o­ra­tor, grantwriter and spokesper­son for virus hunters and gain-of-func­tion/­d­ual-use researchers, in labs both mil­i­tary and civil­ian.

Daszak works with dozens of high-con­tain­ment lab­o­ra­to­ries around the world that col­lect pathogens and use genet­ic engi­neer­ing and syn­thet­ic biol­o­gy to make them more infec­tious, con­ta­gious, lethal or drug-resis­tant. These include labs con­trolled by the U.S. Depart­ment of Defense, in coun­tries in the for­mer Sovi­et Union, the Mid­dle East, South East Asia and Africa.

Many of these labs are staffed by for­mer bio­log­i­cal weapons sci­en­tists. (See Arms Watch’s reports.) Before the Bio­log­i­cal Weapons Con­ven­tion was rat­i­fied, this research was called what it is: bio­log­i­cal weapons research. Now, it’s euphemisti­cal­ly called gain-of-func­tion or dual-use research. 

Gain-of-func­tion research to alter coro­n­avirus­es for the infec­tion of humans goes back to 1999 or ear­li­er, years before the first nov­el coro­n­avirus out­break. On behalf of the U.S. gov­ern­ment, often the mil­i­tary, Daszak scours the globe for ani­mal pathogens and brings them back to the lab to be cat­a­logued, inves­ti­gat­ed and manip­u­lat­ed. . . .”

Key points of analy­sis and dis­cus­sion include:

1.–EcoHealth Alliance con­tracts with the Pen­ta­gon in Tan­za­nia, South Africa, Geor­gia and Malaysia, as well as the U.S.
2.–” . . . . A recent Wired mag­a­zine arti­cle quot­ing Daszak described how a virus col­lect­ed in 2012 was found to be a 96-per­cent match to SARS-CoV­‑2 in 2020 . . . ‘a lack of fund­ing meant they couldn’t fur­ther inves­ti­gate the virus strain now known to be 96 per­cent genet­i­cal­ly sim­i­lar to the virus that caus­es Covid-19’ . . . .”
3.–Daszak’s claim that they could­n’t fur­ther inves­ti­gate that virus because of a lack of fund­ing is dubi­ous, in that recent grants to the orga­ni­za­tion are on top of ” . . . . $100.9 mil­lion that Eco­Health Alliance has received in gov­ern­ment grants and con­tracts since 2003. . . .”
4.–Daszak does not explain how that virus (dis­cov­ered in 2012) turned into SARS-CoV­‑2. ” . . . . Some sci­en­tists say it would take 50 years for RaTG13 [the virus in question–D.E.] to turn into SARS-CoV­‑2. . . .”
5.–Daszak is heav­i­ly net­worked with the Depart­ment of Home­land Secu­ri­ty: ” . . . . the Depart­ment of Home­land Security’s Nation­al Bio­sur­veil­lance Inte­gra­tion Cen­ter (NBIC)  . . . . gave Daszak’s Eco­Health Alliance a $2.2‑million con­tract (2016–2019) to cre­ate a ‘Ground Truth Net­work’ of ‘sub­ject mat­ter experts’ who could pro­vide ‘con­tex­tu­al infor­ma­tion per­tain­ing to bio­log­i­cal events.’ . . . .”
6.–The intel­lec­tu­al and pro­fes­sion­al track record of Daszak and Eco­Health Alliance is porous. Eco­Health Alliance float­ed a canard about Ebo­la poten­tial­ly trav­el­ing to the U.S. ” . . . . an Eco­Health Alliance spokesper­son, spread a false (not to men­tion racist and xeno­pho­bic) nar­ra­tive, one that sub­se­quent­ly would be thor­ough­ly debunked, that bush­meat smug­gled to the U.S. from Africa could trans­mit Ebo­la to Amer­i­cans. . . .”
7.–Daszak missed the boat bad­ly with regard to SARS: ” . . . . It is com­mon­ly accept­ed that the SARS pan­dem­ic began in 2002, when humans caught a bat virus from civet cats at a wet mar­ket in Guang­dong, Chi­na. But Daszak and his col­lab­o­ra­tors admit they have no evi­dence to explain how the virus leapt from bats to civets to humans. . . .”
8.–” . . . . SARS-CoV was found in civets at the Guang­dong wet mar­ket, but civets aren’t the nat­ur­al reser­voir of this virus. Bats are. Only the civets at the market—and no farm-raised or wild civets—carried the virus. None of the ani­mal traders han­dling the civets at the mar­ket had SARS. . . .”
9.–” . . . . When Daszak and his col­lab­o­ra­tors at the WIV searched the cave in Yun­nan for strains of coro­n­avirus sim­i­lar to human ver­sions, no sin­gle bat actu­al­ly had SARS. Genet­ic pieces of the var­i­ous strains would have to be recom­bined to make up the human ver­sion. Adding to the con­fu­sion, Yun­nan is about 1,000 kilo­me­ters from Guang­dong. . . .”
10.–” . . . . So, how did virus­es from bats in Yun­nan com­bine to become dead­ly to humans, and then trav­el to civets and peo­ple in Guang­dong, with­out caus­ing any ill­ness­es along the way dur­ing this 1,000 kilo­me­ter trip? . . .”
11.–Daszak and the Eco­Health Alliance were deeply involved with a USAID and NIH fund­ed joint WIV/University of North Car­oli­na project we have cov­ered exten­sive­ly in past pro­grams. ” . . . . The two insti­tu­tions also worked as col­lab­o­ra­tors under anoth­er $2.6‑million grant, ‘Risk of Viral Emer­gence from Bats,’ and under Eco­Health Alliance’s largest sin­gle source of fund­ing, a $44.2 mil­lion sub-grant from the Uni­ver­si­ty of Cal­i­for­nia at Davis for the PREDICT project (2015–2020). . . .”
12.–” . . . . It’s the $44.2‑million PREDICT grant that Eco­Health Alliance used to fund the gain-of-func­tion exper­i­ment by WIV sci­en­tist Zhengli Shi and the Uni­ver­si­ty of North Car­oli­na at Chapel Hill’s Ralph Bar­ic. Shi and Bar­ic used genet­ic engi­neer­ing and syn­thet­ic biol­o­gy to cre­ate a ‘new bat SARS-like virus . . . that can jump direct­ly from its bat hosts to humans.’ . . .”
13.–” . . . . The work . . . pub­lished in Nature in 2015 dur­ing the NIH’s mora­to­ri­um on gain-of-func­tion research, was grand­fa­thered in because it was ini­ti­at­ed before the mora­to­ri­um (offi­cial­ly called the U.S. Gov­ern­ment Delib­er­a­tive Process Research Fund­ing Pause on Select­ed Gain-of-Func­tion Research Involv­ing Influen­za, MERS and SARS Virus­es), and because the request by Shi and Bar­ic to con­tin­ue their research dur­ing the mora­to­ri­um was approved by the NIH. . . .”
14.–” . . . . As a con­di­tion of pub­li­ca­tion, Nature, like most sci­en­tif­ic jour­nals, requires authors to sub­mit new DNA and RNA sequences to Gen­Bank, the U.S. Nation­al Cen­ter for Biotech­nol­o­gy Infor­ma­tion Data­base. Yet the new SARS-like virus Shi and Bar­ic cre­at­ed wasn’t deposit­ed in Gen­Bank until May 2020. . . .”
15.–” . . . . why is the gov­ern­ment focus­ing on just one of Eco­Health Alliance’s projects, when the orga­ni­za­tion has received $100.9 mil­lion in grants, pri­mar­i­ly from the Depart­ment of Defense, to sam­ple, store and study bat coro­n­avirus­es at labs around the world? Coro­n­avirus­es, both those that have been col­lect­ed from ani­mals and those that have been cre­at­ed through genet­ic engi­neer­ing and syn­thet­ic biol­o­gy, at all of these labs should be com­pared with SARS-CoV­‑2. . . . .”
16.–” . . . . Daszak’s col­lab­o­ra­tors work­ing under con­tracts with the Depart­ment of Health and Human Ser­vices (HHS) aren’t allowed to con­duct gain-of-func­tion research unless specif­i­cal­ly approved to do so by the Poten­tial Pan­dem­ic Pathogen Care and Over­sight (P3CO) com­mit­tee. This com­mit­tee was set up as a con­di­tion for lift­ing the 2014–2017 mora­to­ri­um on gain-of-func­tion research. The P3CO com­mit­tee oper­ates in secret. Not even a mem­ber­ship list has been released. . . .”
17.–Exemplifying Eco­Health Alliance’s work is a Pen­ta­gon con­tract with Tan­za­nia, research­ing CCHF–Crimean-Congo Hem­or­rhag­ic Fever. ” . . . . Eco­Health Alliance has a $5‑million Pen­ta­gon con­tract, ‘Crimean-Con­go Hem­or­rhag­ic Fever: Reduc­ing an Emerg­ing Health Threat in Tan­za­nia.’  Crimean-Con­go Hem­or­rhag­ic Fever (CCHF) is a tick-borne dis­ease, orig­i­nal­ly only infect­ing ani­mals. . . . There was only ever one case of CCHF in Tan­za­nia, and that was in 1986. . . . Gain-of-func­tion research on CCHF is being con­duct­ed at the U.S. Depart­ment of Agriculture’s Nation­al Bio and Agro-Defense Facil­i­ty (NBAF) . . . . (The Nation­al Bio and Agro Defense Facil­i­ty will take over the mis­sion of the Plum Island Ani­mal Dis­ease Cen­ter and become the lead facil­i­ty for For­eign Ani­mal Dis­ease research.) . . .”

Pro­gram High­lights Include: The promi­nent role in the Sanders Insti­tute and AOC’s advi­so­ry team of Jef­frey Sachs, whose HIID team of advis­ers (with gov­ern­ment fund­ing) sent Rus­sia back to the Stone Age, eco­nom­i­cal­ly; the “hand­off” to Jef­frey Sachs and his HIID of Rus­sia and oth­er for­mer Sovi­et Republics by the Gehlen/GOP Nazis man­i­fest­ing through the Free Con­gress Foun­da­tion; review of the oper­a­tional polit­i­cal con­tin­u­um stretch­ing from the Third Reich, through the OSS, the CIA and the GOP; review of the roles of Allen Dulles, William Casey, Resorts Inter­na­tion­al and Don­ald Trump in that con­tin­u­um. 

FTR #1156 Bio-Psy-Op Apocalypse Now, Part 16: An Ounce of Prevention . . . .

In past pro­grams, we have briefly not­ed that mil­i­tary and [osten­si­bly] civil­ian pro­grams offi­cial­ly involved with “epi­dem­ic pre­ven­tion” might con­ceal clan­des­tine bio­log­i­cal war­fare appli­ca­tions designed to cre­ate epi­demics.

This pro­gram fur­ther devel­ops that inquiry

The offi­cial dis­tinc­tion between “offen­sive” and “defen­sive” bio­log­i­cal war­fare research is aca­d­e­m­ic.

In that con­text, one should note that the offi­cial title of Unit 731, the noto­ri­ous Japan­ese bio­log­i­cal war­fare unit was “the Epi­dem­ic Pre­ven­tion and Water Purifi­ca­tion Depart­ment of the Kwan­tung Army.”

Note­wor­thy in that gen­er­al con­text is the obser­va­tion by Jonathan King (pro­fes­sor of mol­e­c­u­lar biol­o­gy at MIT), that Pen­ta­gon research into the appli­ca­tion of genet­ic engi­neer­ing to bio­log­i­cal war­fare could be masked as vac­cine research, which sounds “defen­sive.”

In FTR #1130, we not­ed the role of four-star gen­er­al Gus­tave Per­na in Trump’s “Oper­a­tion Warp Speed,” insti­tut­ed by Gen­er­al Mark Mil­ley, Chair­man of the Joint Chiefs of Staff.

Whether the pro­gram serves as cov­er for mil­i­tary research seems a rea­son­able ques­tion to ask, under the cir­cum­stances.

In our last pro­gram, we weighed New York Times colum­nist Charles Blow’s thoughts about a white-suprema­cist minor­i­ty grouped around the GOP. Blow saw those inter­ests work­ing to pre­serve their priv­i­lege in a num­ber of respects.

This pro­gram asks, in effect, if the glob­al equiv­a­lent of Blow’s male­fac­tors might be doing some­thing sim­i­lar with the Covid-19 “op” and relat­ed, over­lap­ping clan­des­tine oper­a­tions. How might the inter­ests we saw in FTR #1128

Select­ed excerpts of a Whit­ney Webb arti­cle pro­vide insight into the pos­si­ble offen­sive nature of pro­grams osten­si­bly aimed at pre­vent­ing epi­demics. Like Unit 731 (see above), “Epi­dem­ic Pre­ven­tion” may well be mask­ing “epi­dem­ic cre­ation.”

In con­nec­tion with that pos­si­bil­i­ty, the DARPA focus on gene-dri­ving tech­nol­o­gy is fright­en­ing and fraught with dev­as­tat­ing pos­si­bil­i­ties.

Whether or not gene-dri­ving impacts DARPA assist­ed Covid-19 vac­cine devel­op­ment by Mod­er­na and Inovio, the Pen­ta­gon under­writ­ing of these firms is of con­cern.

Some inter­est­ing points raised by Dr. Daniel R. Lucey are par­tic­u­lar­ly impor­tant in light of the infor­ma­tion we have devel­oped in the past about gain of func­tion exper­i­ments.

Lucey’s points of inquiry–although not dis­cussed in this article–are par­tic­u­lar­ly impor­tant when con­sid­ered in con­junc­tion with the joint U.S./Chinese pro­gram to inves­ti­gate bat-borne coro­n­avirus­es, a pro­gram whose Amer­i­can fund­ing appa­ra­tus involved USAID, a fre­quent front for CIA oper­a­tions.

The gain of func­tion exper­i­ments we dis­cussed in FTR #‘s 1116, 1117 and 1121 involv­ing adapt­ing the H5N1 avian flu virus to fer­rets is worth con­tem­plat­ing in the con­text of infor­ma­tion indi­cat­ing that the SARS Cov‑2 virus is par­tic­u­lar­ly infec­tive for fer­rets.

Was part of the mod­i­fied H5N1 flu virus adapt­ed to SARS Cov‑2?

A key fac­tor spurring our sus­pi­cion con­cern­ing genet­ic-engi­neer­ing of one or more vari­ant of the Covid-19 virus con­cerns a 2015 Gain-of-Func­tion exper­i­ment. This should answer Dr. Lucey’s query.

“. . . . Ralph Bar­ic, an infec­tious-dis­ease researcher at the Uni­ver­si­ty of North Car­oli­na at Chapel Hill, last week (Novem­ber 9) pub­lished a study on his team’s efforts to engi­neer a virus with the sur­face pro­tein of the SHC014 coro­n­avirus, found in horse­shoe bats in Chi­na, and the back­bone of one that caus­es human-like severe acute res­pi­ra­to­ry syn­drome (SARS) in mice. The hybrid virus could infect human air­way cells and caused dis­ease in mice. . . . The results demon­strate the abil­i­ty of the SHC014 sur­face pro­tein to bind and infect human cells, val­i­dat­ing con­cerns that this virus—or oth­er coro­n­avirus­es found in bat species—may be capa­ble of mak­ing the leap to peo­ple with­out first evolv­ing in an inter­me­di­ate host, Nature report­ed . . . .”

Crit­ics have flagged Gain-Of-Func­tion research as dan­ger­ous. Pro­po­nents are not dis­suad­ed, includ­ing Peter Daszak. “. . . . But Bar­ic and oth­ers argued the study’s impor­tance. ‘[The results] move this virus from a can­di­date emerg­ing pathogen to a clear and present dan­ger,’ Peter Daszak, pres­i­dent of the Eco­Health Alliance, which sam­ples virus­es from ani­mals and peo­ple in emerg­ing-dis­eases hotspots across the globe, told Nature. . . .”

Of more than pass­ing inter­est is the dis­clo­sure that the project on bat-borne coro­n­avirus­es con­duct­ed in the Wuhan lab­o­ra­to­ry was a joint U.S./Chinese project, and that Ralph Bar­ic was a key Amer­i­can part­ner in the project.

This is the under­tak­ing about which we have report­ed and dis­cussed exten­sive­ly in the past! ” . . . . One of Dr Shi’s co-authors on that paper, Pro­fes­sor Ralph Bar­ic from North Car­oli­na Uni­ver­si­ty, said in an inter­view with ‘Sci­ence Dai­ly’ at the time: ‘This virus is high­ly path­o­gen­ic and treat­ments devel­oped against the orig­i­nal SARS virus in 2002 and the ZMapp drugs used to fight ebo­la fail to neu­tralise and con­trol this par­tic­u­lar virus.’ . . . .”

We note that the WIV project co-fund­ed by USAID involved genet­ic manip­u­la­tion of bat-borne coro­n­avirus­es.

” . . . . Now Dr Richard Ebright, an infec­tious dis­ease expert at Rut­gers Uni­ver­si­ty (USA), has alert­ed the pub­lic to evi­dence that WIV and US-based researchers were genet­i­cal­ly engi­neer­ing bat virus­es to inves­ti­gate their abil­i­ty to infect humans, using com­mon­ly used meth­ods that leave no sign or sig­na­ture of human manip­u­la­tion. Ebright flagged up a sci­en­tif­ic paper pub­lished in 2017 by WIV sci­en­tists, includ­ing Shi Zhengli, the virol­o­gist lead­ing the research into bat coro­n­avirus­es, work­ing in col­lab­o­ra­tion with Peter Daszak of the US-based Eco­Health Alliance. Fund­ing was shared between Chi­nese and US insti­tu­tions, the lat­ter includ­ing the US Nation­al Insti­tutes of Health and USAID. The researchers report hav­ing con­duct­ed virus infec­tiv­i­ty exper­i­ments where genet­ic mate­r­i­al is com­bined from dif­fer­ent vari­eties of SARS-relat­ed coro­n­avirus­es to form nov­el ‘chimeric’ ver­sions. . . .”

In May, the Trump admin­is­tra­tion ter­mi­nat­ed the fund­ing for the project. A key point of analy­sis was set forth by Dr. Chris­tine John­son: ” . . . . Virus sam­ples in labs are almost nev­er still infec­tious, after being frozen in nitro­gen dur­ing the col­lec­tion process and then inac­ti­vat­ed in the lab to pre­serve their genet­ic sequence. . . .

FTR #1155 Bio-Psy-Op Apocalypse, Now Part 15: Covid-19 Updates, Part 4

Con­tin­u­ing cov­er­age of the Covid-19 pandemic–almost cer­tain­ly a bio­log­i­cal war­fare project craft­ed by the U.S. nation­al secu­ri­ty establishment–the broad­cast cen­ters on the dual func­tion of “epi­dem­ic pre­ven­tion” and “epi­dem­ic cau­sa­tion” and sup­ple­ment­ing a Charles Blow op-ed piece in “The New York Times.”

Build­ing on the con­cept (dis­cussed many times in the past) that the dif­fer­ence between “offen­sive” and “defen­sive” bio­log­i­cal war­fare research is aca­d­e­m­ic, we note that cre­den­tialed observers have cit­ed Pen­ta­gon “vac­cine” research as a cov­er for offen­sive BW research. In addi­tion, we observe that numer­ous, over­lap­ping pro­grams osten­si­bly aimed at “pre­vent­ing” epi­demics may well mask efforts at gen­er­at­ing them.

One of the most noto­ri­ous and advanced bio­log­i­cal war­fare pro­grams in his­to­ry was Japan’s Unit 731, meld­ed into the U.S. bio­log­i­cal war­fare pro­gram at the end of World War II. The pro­gram was offi­cial­ly labeled: “the Epi­dem­ic Pre­ven­tion and Water Purifi­ca­tion Depart­ment of the Kwan­tung Army.”

Revis­it­ing the con­sum­mate­ly impor­tant Whit­ney Webb arti­cle about Pen­ta­gon research into bat-borne coro­n­avirus­es, we note:

1.–The DARPA research is osten­si­bly aimed at pre­vent­ing pan­demics but–very possibly–masking prepa­ra­tions for offen­sive bio­log­i­cal war­fare projects.
2.–The Pen­ta­gon is research­ing  “gene-driving”–a biotech­no­log­i­cal devel­op­ment that can per­ma­nent­ly alter the genet­ic make­up of entire pop­u­la­tion groups and lead to the extinc­tion of oth­er groups.
3.–The Pen­ta­gon research is heav­i­ly net­worked with com­pa­nies using DNA and mRNA vac­cines for Covid-19.

The fun­da­men­tal point of analy­sis and dis­cus­sion in this pro­gram, and the next, con­cerns the use of “Epi­dem­ic Pre­ven­tion” to mask exter­mi­na­tion­ist offen­sive bio­log­i­cal war­fare pro­grams to entrench, expand or intro­duce a white-suprema­cist/­First World Dom­i­na­tion dynam­ic in the U.S. and abroad.

Is this the lega­cy of Unit 731, nom­i­nal­ly an “Epi­dem­ic Pre­ven­tion” pro­gram?!

A col­umn by Charles Blow cor­rect­ly notes that the right-wing is work­ing to “lock-in” pow­er. Blow’s obser­va­tion is far more impor­tant when the con­text is expand­ed to include the full-court press against Chi­na and the effects of Covid-19 in the U.S.

Not a super­pow­er at this point in time, Chi­na has made rapid, remark­able progress:

1.–In 1981, 88% of the Chi­nese pop­u­la­tion lived in pover­ty. That was down to 0.7% in 2015.
2.–The Chi­nese mid­dle class was 4% of their pop­u­la­tion in 2002. By 2018, that was up to 31% of their pop­u­la­tion.
3.–In 2000, just 2% of the Chi­nese pop­u­la­tion had access to the inter­net. That was up to 29% by 2009.

With the stun­ning progress made by Chi­na, in com­bi­na­tion with their enor­mous pop­u­la­tion, the nation will be a major pow­er in the future.

Because they are not white and because their sys­tem of state cap­i­tal­ism is at log­ger­heads with the neo-lib­er­al dog­ma to which the West is enthrall, that coun­try will be brought to heel. The anti-Chi­na push by the West is fun­da­men­tal­ly white suprema­cist in nature.

Pur­suant to dis­cus­sion of the Charles Blow col­umn, Mr. Emory reads the head­lines and bylines from a num­ber of New York Times arti­cles under­scor­ing how the pan­dem­ic is work­ing against two trends that Blow cites as inim­i­cal to con­tin­ued GOP con­trol.

The pan­dem­ic is bad­ly dam­ag­ing the for­tunes of urban cen­ters and edu­ca­tion, both at the pub­lic school and uni­ver­si­ty lev­els. In that regard, the pan­dem­ic is accom­plish­ing what the Charles Blow col­umn enun­ci­ates.

Some inter­est­ing points raised by Dr. Daniel R. Lucey are par­tic­u­lar­ly impor­tant in light of the infor­ma­tion we have devel­oped in the past about gain of func­tion exper­i­ments.

Lucey’s points of inquiry–although not dis­cussed in this article–are par­tic­u­lar­ly impor­tant when con­sid­ered in con­junc­tion with the joint U.S./Chinese pro­gram to inves­ti­gate bat-borne coro­n­avirus­es, a pro­gram whose Amer­i­can fund­ing appa­ra­tus involved USAID, a fre­quent front for CIA oper­a­tions.

The gain of func­tion exper­i­ments we dis­cussed in FTR #‘s 1116, 1117 and 1121 involv­ing adapt­ing the H5N1 avian flu virus to fer­rets is worth con­tem­plat­ing in the con­text of infor­ma­tion indi­cat­ing that the SARS Cov‑2 virus is par­tic­u­lar­ly infec­tive for fer­rets.

Was part of the mod­i­fied H5N1 flu virus adapt­ed to SARS Cov‑2?

Anoth­er sub­ject worth con­tem­plat­ing con­cerns Gilead Sci­ences, Tam­i­flu and the prog­nos­ti­ca­tions con­cern­ing a “twindem­ic” this fall, with influen­za and Covid-19 com­bin­ing to over­whelm the health sys­tem.

Might we see an enhanced H5N1 avian influen­za this fall, pro­vid­ing enor­mous prof­its to Gilead Sci­ences, which, as we saw in FTR #1138, made an enor­mous amount of mon­ey (for itself and for­mer Chair­man of the Board Don­ald Rums­feld) devel­op­ing Tam­i­flu to negate the pos­si­bil­i­ty of an H5N1 pan­dem­ic?

A key fac­tor spurring our sus­pi­cion con­cern­ing genet­ic-engi­neer­ing of one or more vari­ant of the Covid-19 virus con­cerns a 2015 Gain-of-Func­tion exper­i­ment per­formed by Ralph Bar­ic, employed in a joint U.S./Chinese exper­i­ment part­ly financed by USAID (a front for CIA activ­i­ty in the past) and NIH (used by both CIA and the Pen­ta­gon in the past). In that project, Bar­ic: ” . . . . pub­lished a study on his team’s efforts to engi­neer a virus with the sur­face pro­tein of the SHC014 coro­n­avirus, found in horse­shoe bats in Chi­na, and the back­bone of one that caus­es human-like severe acute res­pi­ra­to­ry syn­drome (SARS) in mice. The hybrid virus could infect human air­way cells and caused dis­ease in mice. . . . The results demon­strate the abil­i­ty of the SHC014 sur­face pro­tein to bind and infect human cells, val­i­dat­ing con­cerns that this virus—or oth­er coro­n­avirus­es found in bat species—may be capa­ble of mak­ing the leap to peo­ple with­out first evolv­ing in an inter­me­di­ate host . . .” 

Of more than pass­ing inter­est is the dis­clo­sure that the project on bat-borne coro­n­avirus­es con­duct­ed in the Wuhan lab­o­ra­to­ry was a joint U.S./Chinese project, and that Ralph Bar­ic was a key Amer­i­can part­ner in the project.

This is the under­tak­ing about which we have report­ed and dis­cussed exten­sive­ly in the past! ” . . . . One of Dr Shi’s co-authors on that paper, Pro­fes­sor Ralph Bar­ic from North Car­oli­na Uni­ver­si­ty, said in an inter­view with ‘Sci­ence Dai­ly’ at the time: ‘This virus is high­ly path­o­gen­ic and treat­ments devel­oped against the orig­i­nal SARS virus in 2002 and the ZMapp drugs used to fight ebo­la fail to neu­tralise and con­trol this par­tic­u­lar virus.’ . . . .”

FTR #1152 Bio-Psy-Op Apocalypse Now, Part 12: Covid-19 Updates, Part 3

Flesh­ing out under­stand­ing of Covid-19, this pro­gram looks at the inter­re­la­tion­ship between ele­ments of the mil­i­tary, big phar­ma, ther­a­peu­tic mea­sures select­ed for ear­ly deploy­ment against the pan­dem­ic and the full-court press under­way against Chi­na.

Specif­i­cal­ly, we won­der if the DARPA research into bat-borne coro­n­avirus­es and the appar­ent dis­sem­i­na­tion of Covid-19 as part of the covert oper­a­tions con­stel­la­tion being direct­ed against Chi­na may have dri­ven devel­op­ment of those ther­a­peu­tic mea­sures.

In March of this year, the Pen­ta­gon secured remde­sivir for treat­ing U.S. ser­vice per­son­nel. In FTR #1138, we looked at remde­sivir  being test­ed on rhe­sus macaques in March of 2019. In August of last year, the CDC  closed down the Unit­ed States Army Med­ical Insti­tute of Infec­tious Dis­eases, in part because of defi­cient han­dling of waste pro­duced by “non-human” pri­mates infect­ed with an unnamed “select agent.”

Was that “select agent” Ebo­la? A bat-borne coro­n­avirus? SARS CoV‑2?

Remde­sivir was def­i­nite­ly being test­ed on MERS at a facil­i­ty in Mon­tana that was a base for Willy Burgdor­fer­’s bio­log­i­cal war­fare research result­ing the devel­op­ment of Lyme Dis­ease.

The MERS virus was also a focal point for test­ing of the mes­sen­ger RNA vac­cines being devel­oped (large­ly under DARPA aus­pices). That test­ing appears to have been a fac­tor in fast-track­ing the Mod­er­na vac­cine for SARS CoV‑2 (see below).

Next, we review ele­ments of a thought-pro­vok­ing and dis­turb­ing arti­cle about DARPA research into bat-borne dis­eases, includ­ing some caused by coro­n­avirus­es.

As read­ers digest this infor­ma­tion, remem­ber that DARPA can bring to bear the twined tech­nolo­gies arti­fi­cial intel­li­gence and super-com­put­ers. It has the state of the art with respect to both. Com­bined with gene edit­ing, that tech­no­log­i­cal pair­ing offers the pos­si­bil­i­ty of tru­ly hor­ri­fy­ing syn­thet­ic virus­es.

Whit­ney Webb has pro­vid­ed us with trou­bling insight into Pen­ta­gon research–some of which remains clas­si­fied, includ­ing:

1.–DARPA’s study of “gene-dri­ving tech­nol­o­gy”–” . . . . Con­cerns about Pen­ta­gon exper­i­ments with bio­log­i­cal weapons have gar­nered renewed media atten­tion, par­tic­u­lar­ly after it was revealed in 2017 that DARPA was the top fun­der of the con­tro­ver­sial ‘gene dri­ve’ tech­nol­o­gy, which has the pow­er to per­ma­nent­ly alter the genet­ics of entire pop­u­la­tions while tar­get­ing oth­ers for extinc­tion. . . .”
2.–DARPA’s fund­ing of Mod­er­na’s mRNA vac­cine tech­nol­o­gy.
3.–The clo­sure of the USAMRIID:” . . . . The U.S. Army Med­ical Research Insti­tute of Infec­tious Dis­eases (USAMRIID) facil­i­ty at Fort Det­rick, Mary­land — the U.S. military’s lead lab­o­ra­to­ry for ‘bio­log­i­cal defense’ research since the late 1960s — was forced to halt all research it was con­duct­ing with a series of dead­ly pathogens . . . . USAMRIID has recent­ly been involved in research born out of the Pentagon’s recent con­cern about the use of bats as bioweapons. . . .”

Moderna’s SARS-CoV­‑2 vac­cine con­tin­ues to gen­er­ate con­tro­ver­sy. Despite receiv­ing fund­ing from DARPA, no men­tion of the gov­ern­ment back­ing was men­tioned in its patent fil­ings.

While Mod­er­na was not open about its exten­sive gov­ern­ment sup­port in patent fil­ings, the com­pa­ny has been open about it with the press–for good rea­son: the fast-track­ing of Moderna’s COVID-19 vac­cine devel­op­ment has been jus­ti­fied in large part because of that exten­sive past gov­ern­ment sup­port. That sup­port high­lights the close work Mod­er­na and US gov­ern­ment agen­cies have con­duct­ed togeth­er over the years devel­op­ing this vac­cine tech­nol­o­gy for MERS. Might this devel­op­ment have been part of the DARPA research dis­cussed in the Whit­ney Webb arti­cle?

Next, we high­light a Nature arti­cle from last month describ­ing the exist­ing col­lab­o­ra­tion between the NIAID’s Vac­cine Research Cen­ter and Mod­er­na on a dif­fer­ent vac­cine. Mod­er­na sim­ply shift­ed gears and start­ed work­ing on the COVID-19 vac­cine: it’s been a US government/Moderna col­lab­o­ra­tion from the very begin­ning.

An aspect of Mod­er­na’s vac­cine devel­op­ment that is of con­cern is the fact that mRNA vac­cines are inex­pen­sive to pro­duce, facil­i­tat­ing the pro­duc­tion of large amounts of stock. This, in turn, IF it is announced before elec­tion day, might not only boost Trump’s pop­u­lar­i­ty, but such a devel­op­ment could pro­vide a foun­da­tion for an assault on mail-in vot­ing.

The news out of Moderna’s tri­al could be worse. The extreme­ly small size of this sam­ple, how­ev­er, is a mat­ter of con­cern.

Note­wor­thy in that gen­er­al con­text is the obser­va­tion by Jonathan King (pro­fes­sor of mol­e­c­u­lar biol­o­gy at MIT), that Pen­ta­gon research into the appli­ca­tion of genet­ic engi­neer­ing to bio­log­i­cal war­fare could be masked as vac­cine research, which sounds “defen­sive.”

In FTR #1130, we not­ed the role of four-star gen­er­al Gus­tave Per­na in Trump’s “Oper­a­tion Warp Speed,” insti­tut­ed by Gen­er­al Mark Mil­ley, Chair­man of the Joint Chiefs of Staff.

Whether the pro­gram serves as cov­er for mil­i­tary research seems a rea­son­able ques­tion to ask, under the cir­cum­stances.

We con­clude with a look at the past–a his­tor­i­cal ele­ment of bio­log­i­cal war­fare that reflects on the present.

In past pro­grams and posts, we have briefly not­ed that mil­i­tary and [osten­si­bly] civil­ian pro­grams offi­cial­ly involved with “epi­dem­ic pre­ven­tion” might con­ceal clan­des­tine bio­log­i­cal war­fare appli­ca­tions designed to cre­ate epi­demics.

The offi­cial dis­tinc­tion between “offen­sive” and “defen­sive” bio­log­i­cal war­fare research is aca­d­e­m­ic.

In that con­text, one should note that the offi­cial title of Unit 731, the noto­ri­ous Japan­ese bio­log­i­cal war­fare unit was “the Epi­dem­ic Pre­ven­tion and Water Purifi­ca­tion Depart­ment of the Kwan­tung Army.”

The Whit­ney Webb article–once again–figures into this analy­sis:

The DARPA research is osten­si­bly aimed at pre­vent­ing pan­demics but–very possibly–masking prepa­ra­tions for offen­sive bio­log­i­cal war­fare projects. ” . . . . Many of these recent research projects are relat­ed to DARPA’s Pre­vent­ing Emerg­ing Path­o­gen­ic Threats, or PREEMPT pro­gram, which was offi­cial­ly announced in April 2018. PREEMPT focus­es specif­i­cal­ly on ani­mal reser­voirs of dis­ease, specif­i­cal­ly bats, and DARPA even not­ed in its press release in the pro­gram that it ‘is aware of biosafe­ty and biose­cu­ri­ty sen­si­tiv­i­ties that could arise’ due to the nature of the research. . . . In addi­tion, while both DARPA’s PREEMPT pro­gram and the Pentagon’s open inter­est in bats as bioweapons were announced in 2018, the U.S. mil­i­tary — specif­i­cal­ly the Depart­ment of Defense’s Coop­er­a­tive Threat Reduc­tion Pro­gram — began fund­ing research involv­ing bats and dead­ly pathogens, includ­ing the coro­n­avirus­es MERS and SARS, a year pri­or in 2017. . . .”
Look­ing ahead to our next pro­gram (and to the fore­casts of a “twindemic”–seasonal flu and Covid-19 at the same time) we note the obser­va­tions of Dr. Daniel R. Lucey, who has cit­ed Chi­nese research that fer­rets are par­tic­u­lar­ly sus­cep­ti­ble to SARS COV‑2 infec­tion.

In FTR #‘s 1116 and 1117, we not­ed the gain-of-func­tion exper­i­ments being done on H5N1 avian flu. Specif­i­cal­ly, the virus was mutat­ed to man­i­fest upper res­pi­ra­to­ry trans­mis­sion in fer­rets.

In FTR #1138, we not­ed that Tamiflu–developed by Gilead Sci­ences (the mak­ers of remde­sivir) was devel­oped to com­bat the fore­cast H5N1 pan­dem­ic. For­mer chair­man-of-the board Don­ald Rums­feld, prof­it­ed enor­mous­ly from Pen­ta­gon and gov­ern­ment pur­chas­es of Tam­i­flu.

We won­der about:

1.–The pos­si­bil­i­ty of the GOF func­tions done on H5N1 hav­ing been applied to the devel­op­ment of SARS Cov‑2.
2.–The pos­si­bil­i­ty that the GOF func­tions done on H5N1 could result in a more vir­u­lent H5N1 pan­dem­ic, coin­cid­ing with Covid-19.
3.–The pos­si­bil­i­ty that the above devel­op­ments may prove very prof­itable to Gilead Sci­ences.

FTR #1151 Bio-Psy-Op Apocalypse Now, Part 11: Covid-19 Updates, Part 2

Con­tin­u­ing our inquiry into the Covid-19 pan­dem­ic, this pro­gram con­tin­ues analy­sis of the dis­ease as a pandemic–a bio­log­i­cal war­fare man­i­fes­ta­tion that is one part act of war, one part domes­tic ter­ror­ism, and a major “psy-op.”

The wide­ly pub­li­cized inter­view Trump gave to Bob Wood­ward, in which Trump can­did­ly assessed the lethal nature of SARS Cov‑2 has been mis­un­der­stood. Trump’s pol­i­cy on the virus has been just exact­ly what he and the inter­ests for which he fronts desire.

The pan­dem­ic is a por­tal for the real­iza­tion of the goals of the Under­ground Reich for which Trump is a front man and enabler. These issues either have been or will be dis­cussed at greater length.

The virus is the Wealth Con­cen­tra­tion Virus.
It is the Wealth-Destroy­ing Virus for areas and insti­tu­tions that the Trump inter­ests oppose.
It is the Urban Area Destruc­tion Virus.
It is the White Suprema­cist Virus–hitting peo­ple of col­or much hard­er, due to health and socio-eco­nom­ic fac­tors.
It is the Eugenic Virus–killing old­er peo­ple and peo­ple with com­pli­cat­ing med­ical con­di­tions.
It is the Edu­ca­tion-Destroy­ing Virus, dras­ti­cal­ly and neg­a­tive­ly affect­ing pub­lic schools and col­leges.
It is the Pub­lic Tran­sit Destroy­ing Virus.
It is the Divide and Con­quer Virus–separating the old from the young and–potentially–women from men.
The pan­dem­ic is the “Bio-Psy-Op Apoc­a­lypse” Virus, rav­aging the psy­ches of indi­vid­u­als and groups.
Trump kept a copy of this by his bed­side for late-night read­ing.

The Covid-19 pan­dem­ic is dri­ving what might be termed a right-wing ide­o­log­i­cal wet dream in a num­ber of dif­fer­ent respects. Here, we note that the dam­age done by the virus is seen as fur­ther­ing a cor­po­ratist agen­da, mas­querad­ing under the com­mon rhetor­i­cal cam­ou­flage of “lib­er­tar­i­an” phi­los­o­phy.

An impor­tant piece in “The Guardian” details how plu­to­crats terming them­selves “anar­cho-cap­i­tal­ists” see the pan­dem­ic as forc­ing regions–from nations to municipalities–to con­form to the demands of dom­i­nant, mobile blocks of cap­i­tal by elim­i­nat­ing the essen­tials of the pro­gres­sive social agen­da.

1.–” . . . . They spy oppor­tu­ni­ty in the cri­sis, and wager that we might be able to ride the wave of the pan­dem­ic into a new tomor­row, where the virus shat­ters the glob­al map – and under­mines the pow­er of demo­c­ra­t­ic nation states. The US is ground zero for this type of think­ing. . . .”
2.–” . . . . In an analy­sis released at the end of April, Arthur Laf­fer and Stephen Moore, two of Trump’s clos­est eco­nom­ic con­fi­dants and authors of the book on ‘Trumpo­nom­ics’, pre­dict­ed that ‘blue’ Demo­c­ra­t­ic states would be slow­er than ‘red’ states to recov­er, because of what they saw as their pre-exist­ing excess of reg­u­la­tions and tax­es. . . .”
3.–” . . . .Their analy­sis divid­ed the US map into ‘lag­gard anti-growth’ states and ‘momen­tum pro-growth’ states. The for­mer have min­i­mum wages, pro-union laws and state income tax; the lat­ter are free of such reg­u­la­tions. In the estab­lished mode of dis­as­ter cap­i­tal­ism, Laf­fer and Moore’s analy­sis appears to see the pan­dem­ic as a way to com­pel ‘anti-growth’ states to adopt ever low­er tax rates in order to attract mobile cap­i­tal and labour. It sug­gests those who resist will not be bailed out by redis­tri­b­u­tion from the cen­tral gov­ern­ment, but left to lan­guish in a deserved eco­nom­ic depres­sion. The effect is rem­i­nis­cent of social Dar­win­ism, applied as a phi­los­o­phy of gov­ern­ment. . . .”
4.–” . . . . As nations are divid­ed into dif­fer­ent zones accord­ing to their respec­tive stages of viral and eco­nom­ic recov­ery, the well-off could fol­low Elon Musk’s recent threat to relo­cate from Cal­i­for­nia to Texas, vot­ing with their feet for loca­tions that elude redis­trib­u­tive tax­a­tion. In our post-pan­dem­ic future, the flight to safe­ty, away from con­ta­gious ‘red zones’, could be a flight from the nation state as we know it. . . .”

As an intro­duc­tion, we review key aspects of a very impor­tant arti­cle by Whit­ney Webb, set­ting forth exten­sive DARPA research into bat-borne coro­n­avirus­es, poten­tial­ly geno­ci­dal gene-dri­ving tech­nol­o­gy and over­lap­ping research into vac­cine devel­op­ment, as well as the pos­si­bil­i­ty that such research may have been involved with the CDC’s shut­down of Fort Det­rick­’s USAMRIID in ear­ly August of 2019.

In numer­ous pro­grams, we have not­ed remde­sivir and how it has driven–very pos­si­bly with insid­er advanced knowl­edge and trading–the stock mar­ket. We have cov­ered remde­sivir and Gilead Sci­ences in detail in FTR #‘s 1132, 1134, and 1138.

The FDA–now head­ed by the Hoover Insti­tute’s Stephen Hahn, a for­mer can­cer spe­cial­ist with no expe­ri­ence in infec­tious diseases–has expand­ed the approved use of remde­sivir. Experts are warn­ing that the FDA pro­vid­ed no data jus­ti­fy­ing the move and now the drug is going to be in even short­er sup­ply for the sick­est patients.

The remain­der of the pro­gram focus­es on fast-track­ing of vac­cines.

Among the gam­bits being dis­cussed as pos­si­ble vehi­cles for Trump to gain a sec­ond term is the roll­out of a Covid-19 vac­cine. The CDC has told states to pre­pare for such a devel­op­ment. Many crit­ics have cit­ed the pre­ma­ture nature of such a pos­si­bil­i­ty and the lack of ade­quate test­ing.

Next, we present an inter­view of the head of the FDA, Stephen Hahn, about his will­ing­ness to fast-track a vac­cine. The way Hahn puts it, the cri­te­ria for his deci­sion to fast track is sim­ply as long as the ben­e­fits out­weigh the risks.

Hahn comes from the Hoover Insti­tute. His med­ical expe­ri­ence is in the field of can­cer treat­ment. He has no expe­ri­ence in infec­tious dis­eases.

As crit­ics point out, even if ear­ly results are over­whelm­ing­ly pos­i­tive that doesn’t pre­clude the pos­si­bil­i­ty of dan­ger­ous side effects tak­ing longer to man­i­fest. In addi­tion, end­ing the tri­al ear­ly reduces oppor­tu­ni­ty to recruit more peo­ple from groups cur­rent­ly under-rep­re­sent­ed in tri­als, such as blacks and His­pan­ics. End­ing the tri­als ear­ly due to very pos­i­tive ini­tial results might hide dele­te­ri­ous results down the line, par­tic­u­lar­ly for the non-whites that Trump and his base despise.

Antho­ny Fau­ci has indi­cat­ed the pos­si­bil­i­ty of such an ear­ly autho­riza­tion.

Next, we present an inter­view with a pre­vi­ous FDA chief, Scott Got­tlieb, who sits on the board of Pfizer–along with Mod­er­na, lead­ing the race to get a vac­cine to mar­ket.

One sce­nario he saw as fea­si­ble for a pre-elec­tion vac­cine release: if clin­i­cal tri­als demon­strate that the vac­cine is high­ly effec­tive in the mid­dle of a new “dense” wave of cas­es.

FTR #1150 The Space Plane and Covid-19: The Paperclip Legacy, Part 5

This pro­gram com­pletes the line of inquiry we under­took in FTR #‘s 1146, 1147, 1148 and 1149. Most impor­tant­ly, we bring the evo­lu­tion of events and insti­tu­tions up to the present. Lis­ten­ers who digest the pro­grams in the future should bear in mind that these pro­grams were record­ed dur­ing, and in the imme­di­ate after­math of, the 2020 GOP con­ven­tion.

After review­ing infor­ma­tion about Nixon con­fi­dante Bebe Rebo­zo and the links of his bank to the dead­ly Bor­mann net­work, we con­tin­ue with the unpub­lished man­u­script from which we read in our last pro­gram. The broad­cast high­lights inter­ac­tions between the Nixon admin­is­tra­tion, Bebe Rebo­zo, a mys­te­ri­ous and alleged­ly orga­nized-crime con­nect­ed com­pa­ny called Resorts Inter­na­tion­al, an even more mys­te­ri­ous sub­sidiary of Resorts Inter­na­tion­al called the Par­adise Island Bridge Com­pa­ny and the Dewey, Dulles, Nazi, William Casey milieu that is cen­tral to this dis­cus­sion.

The Par­adise Island Bridge Com­pa­ny’s direc­tors are sug­ges­tive of a pos­si­ble Bor­mann link: ” . . . . It did, how­ev­er, name a num­ber of Ger­man and Swiss investors, One of these, for exam­ple, was Dr. Heinz Ros­terg of Lau­sanne, a for­mer ‘prin­ci­pal stock­hold­er’ and direc­tor of the Win­ter­shall potash con­cern; Win­ter­shall was one of the major sub­sidiaries of BASF, the largest sin­gle suc­ces­sor firm to I.G. Far­ben. . . . .”

The man­u­script sets forth spec­u­la­tion about the pos­si­bil­i­ty that Mary Carter Paint/Resorts Inter­na­tion­al may have gen­er­at­ed funds that greased the wheels for the release of many Nazi war crim­i­nals. ” . . . . Still unan­swered is the ques­tion of whether the sto­ry of the Dewey-Allen Dulles inter­est in Resorts should have referred to funds, not from the CIA itself, but from its Ger­man-Swiss part­ners in the Par­adise Island Bridge Com­pa­ny. Such a hypoth­e­sis might explain some of the many strange coin­ci­dences which sur­round the com­pa­ny’s con­tro­ver­sial his­to­ry. It might, for exam­ple, explain the ‘for­tune in legal fees’ that Mary Carter Paint, on the advice of Thomas Dewey, paid to Allen Dulles’ long­time law part­ner David Peck. (48) The SS-OSS con­nec­tion cer­tain­ly had rea­son to be grate­ful to David Peck. It was on the basis of Peck­’s rec­om­men­da­tion, as chair­man of a three-man advi­so­ry board to review all the Nurem­berg sen­tences, that John J. McCloy com­mut­ed to time served the sen­tence of Sko­rzeny’s post-war employ­er, Baron Alfried Krupp, and eight of his col­leagues, and also ordered Krup­p’s prop­er­ty to be restored. (49) The release of Krupp and oth­er indus­tri­al­ists ful­filled an ear­li­er demand to McCloy from Her­mann Abs, who him­self nar­row­ly escaped pros­e­cu­tion at Nurem­berg. Abs was the first post-war chair­man of BASF, the I.G. Far­ben suc­ces­sor com­pa­ny rep­re­sent­ed among the stock­hold­ers of the Par­adise Island Bridge Com­pa­ny. (50) . . . .”

William Casey

The author also engages in spec­u­la­tion about the rela­tion­ship between Resorts Inter­na­tion­al and Cap­i­tal Cities Broad­cast­ing. The lat­ter is the com­pa­ny that bought out ABC in the mid 1980’s and whose largest stock­hold­er was William Casey. ” . . . . Might not the OSS-SS con­nec­tion also throw light on the unex­plained inter­lock between James Cros­by’s com­pa­ny Resorts Inter­na­tion­al, tight­ly con­trolled by the relat­ed and dou­bly inter­mar­ried Cros­by-Mur­phy fam­i­lies, and Cap­i­tal Cities Broad­cast­ing, the major invest­ment of the CIA’s present direc­tor William Casey. (51) Casey would be the log­i­cal per­son to have estab­lished the orig­i­nal con­nec­tion between the Cros­by-Mur­phy fam­i­lies and their mys­te­ri­ous Ger­man-Swiss part­ners. For it was Casey who, in 1944–45, ‘was giv­en over­all oper­a­tional con­trol of [OSS] Ger­man projects,’ and ‘co-ordi­nat­ed . . . the over 150 men’ whom OSS sent into Ger­many. (52) With Dulles, Wis­ner, and For­gan, Casey was also one of the OSS vet­er­ans who lob­bied suc­cess­ful­ly for a CIA which could legit­i­mate­ly uti­lize the resources of the Gehlen Org. (53) . . .”

The “unex­plained inter­lock” between Resorts Inter­na­tion­al and Cap­i­tal Cities is described by the author: ” . . . . James Cros­by’s cousin and broth­er-in-law, Thomas S. Mur­phy, was in 1964, the Exec­u­tive Vice-Pres­i­dent and a direc­tor of Cap­i­tal Cities, as well as a direc­tor of Mary Carter Paint. Low­ell Thomas, a long-time radio broad­cast­er with intel­li­gence con­nec­tions, was a direc­tor of both com­pa­nies. At the time, William Casey was an offi­cer, direc­tor, and major stock­hold­er of Cap­i­tal Cities. . . .”

Trump kept a copy of this by his bed­side for late-night read­ing.

After James Cros­by’s “unex­pect­ed” death in April of 1986, Don­ald Trump–whose oper­a­tions are bankrolled by Deutsche Bank–purchased the com­pa­ny. Fol­low­ing lit­i­ga­tion with Merv Grif­fin, the assets were divid­ed with the tele­vi­sion per­son­al­i­ty. ”  . . . . Real estate devel­op­er Don­ald Trump, who owned two Atlantic City casi­nos, beat out sev­er­al oth­er bid­ders to pur­chase a con­trol­ling stake in the com­pa­ny from Cros­by’s fam­i­ly for $79 mil­lion in July 1987.[26] Trump was appoint­ed chair­man of Resorts Inter­na­tion­al, and said he would com­plete the Taj Mahal in about a year. . . . The two ulti­mate­ly reached a set­tle­ment, which was exe­cut­ed in Novem­ber 1988, with Grif­fin pur­chas­ing the com­pa­ny for $365 mil­lion, and Trump pur­chas­ing the Taj Mahal from the com­pa­ny for $273 mil­lion. . . .”

Pro­gram High­lights Include:

1.–Discussion of Cap­i­tal Cities Broad­cast­ing’s acqui­si­tion of ABC fol­low­ing the CIA’s fil­ing of a “fair­ness doc­trine” com­plaint against the com­pa­ny for their cov­er­age of Bish­op, Bald­win, Rewald, Dilling­ham and Wong. Ron Rewald alleged that he and the firm for which he worked front­ed for CIA. (At the time William Casey was head of CIA and Cap­i­tal Cities largest stock­hold­er.)
2.–The fact that Thomas Dewey, two time GOP can­di­date for Pres­i­dent, was one of the founders of Cap­i­tal Cities. The gen­e­sis of the Nazi branch of the GOP was Dewey’s 1948 cam­paign.
3.–Review of William Casey’s career, includ­ing the posi­tions he held in the Nixon admin­is­tra­tion and his involve­ment with the Black Eagle Trust, which evolved from the Gold­en Lily plun­der acquired by Japan after World War II.
4.–Discussion of Attor­ney Gen­er­al William Bar­r’s back­ground in the CIA, includ­ing his role in George H.W. Bush’s par­don of key play­ers in the Iran-Con­tra scan­dal.
5.–Analysis of Bar­r’s father Don­ald Barr and his work for the OSS in World War II, which may have inter­sect­ed with the machi­na­tions of Dulles, Dono­van, Casey and the Nazi “Oper­a­tion Sun­rise” par­tic­i­pants.
6.–Donald Bar­r’s hir­ing of col­lege dropout Jef­frey Epstein to teach at the Dal­ton School.
7.–Donald Bar­r’s author­ship of a sci­ence fic­tion novel–Space Relations–about a plan­et dom­i­nat­ed by oli­garchs and dri­ven by sex­u­al slav­ery.
8.–Review of a deci­sive strat­a­gem of the Under­ground Reich, enun­ci­at­ed by Army offi­cer Glenn Pinch­back in a let­ter to New Orleans D.A. Jim Gar­ri­son. Pinch­back wrote of a ” . . . . ‘Neo-Nazi plot to enslave Amer­i­ca in the name of anti-Com­mu­nism,’ . . .”
9.–In past pro­grams, we have briefly not­ed that mil­i­tary and [osten­si­bly] civil­ian pro­grams offi­cial­ly involved with “epi­dem­ic pre­ven­tion” might con­ceal clan­des­tine bio­log­i­cal war­fare appli­ca­tions designed to cre­ate epi­demics. The offi­cial dis­tinc­tion between “offen­sive” and “defen­sive” bio­log­i­cal war­fare research is aca­d­e­m­ic. In that con­text, one should note that the offi­cial title of Unit 731, the noto­ri­ous Japan­ese bio­log­i­cal war­fare unit was “the Epi­dem­ic Pre­ven­tion and Water Purifi­ca­tion Depart­ment of the Kwan­tung Army.” Unit 731’s research was incor­po­rat­ed into the U.S. bio­log­i­cal war­fare pro­gram at the end of World War II.
10.–Noteworthy in that gen­er­al con­text is the obser­va­tion by Jonathan King (pro­fes­sor of mol­e­c­u­lar biol­o­gy at MIT), that Pen­ta­gon research into the appli­ca­tion of genet­ic engi­neer­ing to bio­log­i­cal war­fare could be masked as vac­cine research, which sounds “defen­sive.”